Aarva

Aarva

The world as your classroom, the finest journalism as your curriculum. Written by humans. Narrated by AI. Every day, you get a selection of handpicked articles from across a spectrum of topics, meant to delight, indulge curiosity and expand your mind. You also get one edition of "Crosscuts" every day, where you get two potentially diverse-seeming articles but with an interesting, even surprising connection. It is intended to show how we can spot connections and patterns in surprising ways. This is journalism that delights, educates and expands our minds. Not the anxiety-inducing cycle of breaking news. For more features and details, visit https://aarva.app/

  1. -8 ч

    Crosscut: weight loss drugs

    A beauty salon hands out a syringe as casually as a facial treatment. That detail, from a Scroll.in investigation published earlier this month by Tabassum Barnagarwala, captures the cosmetic frenzy surrounding GLP-1 drugs. But treating these injections as unregulated slimming packages obscures what is happening in clinical trials. Writing for Vox just yesterday, Bryan Walsh looks at the medical reality behind the vanity hype. These medications are treating sleep apnea and kidney disease, doing far more than altering a waistline. What emerges from these two pieces is a strange friction. It is worth pausing on the gap between how a culture turns a medication into a beauty product, and the life-saving work that drug performs inside the body. Reading Tabassum Barnagarwala, the image that sticks is a customer paying thousands of rupees at a local beauty salon for a serious hormone injection. She leaves you with a sharp sense of the danger that comes from treating a heavy-duty medical tool like a cosmetic quick fix. Bryan Walsh, up next, looks at that exact same cultural obsession with weight loss, but he takes it in a completely different direction. Where Barnagarwala focuses on the physical harm of handing out these drugs like beauty treatments, Walsh points out how that cosmetic hype is actually blinding people to the real story. He argues that focusing so intensely on waistlines means ignoring the fact that these medications are now treating everything from sleep apnea to kidney disease. Put the two together, and a striking picture emerges. The cultural fixation on getting thin isn't just driving people to make dangerous choices at unregulated clinics. It is also drowning out the quieter, life-saving medical realities of what these drugs actually do to the human body. What lingers is the image of that same clear liquid sitting in two very different rooms. Next to a salon chair, a syringe promises a thinner waist. Inside a clinical trial, it heals a failing kidney. The friction sits right there. A powerful medication is handed out like a spray tan, while its ability to treat sleep apnea gets buried under the noise of getting thin. When a medical breakthrough is permanently branded as a cosmetic luxury, who gets left waiting for an actual cure? Sources: Scroll.in: The dark side of the booming Indian market for weight-loss drugs Vox: Ozempic is not just a weight-loss story anymore For more features and details, visit aarva.app

Об этом подкасте

The world as your classroom, the finest journalism as your curriculum. Written by humans. Narrated by AI. Every day, you get a selection of handpicked articles from across a spectrum of topics, meant to delight, indulge curiosity and expand your mind. You also get one edition of "Crosscuts" every day, where you get two potentially diverse-seeming articles but with an interesting, even surprising connection. It is intended to show how we can spot connections and patterns in surprising ways. This is journalism that delights, educates and expands our minds. Not the anxiety-inducing cycle of breaking news. For more features and details, visit https://aarva.app/

Вам может также понравиться